account
involv
hemostat
system
sever
pneumonia
come
major
surpris
hemostasi
commun
involv
sepsi
initi
dic
well
document
nevertheless
whether
particular
viru
prone
dic
develop
need
follow
close
epidem
evolv
pathophysiolog
dic
complex
multifactori
involv
interplay
cellular
plasmat
element
hemostat
system
compon
innat
immun
respons
infect
pathogen
activ
vascular
endothelium
platelet
leukocyt
result
dysregul
thrombin
gener
occur
system
local
lung
patient
sever
pneumonia
result
deposit
fibrin
subsequ
tissu
damag
microangiopath
patholog
evolv
evid
combin
activ
event
initi
exposur
endothelium
platelet
leukocyt
pathogenand
damageassoci
molecular
pattern
primari
instig
pathophysiolog
effect
dysregul
thrombin
gener
exacerb
inhibit
fibrinolysi
impair
natur
anticoagul
mechan
date
treatment
dic
focus
strategi
target
primari
associ
patholog
cours
limit
case
infect
learnt
effect
antivir
agent
new
pathogen
otherwis
support
care
maintain
critic
organ
function
requir
trial
natur
anticoagul
infus
met
variabl
outcom
although
recent
experi
solubl
thrombomodulin
product
appear
promis
epidem
progress
learn
propens
agent
engag
innat
immun
hemostat
system
two
critic
emerg
respons
pathway
maintain
homeostasi
control
circumst
produc
sever
patholog
present
dysregul
condit
observ
tang
colleagu
provid
earli
evid
enhanc
vigil
requir
identifi
emerg
dic
pneumonia
patient
author
declar
conflict
interest
